Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: inadequate (44), deficient (6), lacking (201), not enough (312), scarce (3), unsatisfactory (16)

Papers Trust Board - 13 January 2026

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education C
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

UHS AR 22-23-6

Description: 2022/23 Incorporating the quality account University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2022/23 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-22-23-6.pdf

Selinexor Bortezomib Dexamethasone

Description: Chemotherapy Protocol Multiple Myeloma Selinexor with Bortezomib and Dexamethasone Regimen • SELINEXOR (PO) – BORTEZOMIB (SC) – DEXAMETHASONE
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Selinexor-Bortezomib-Dexamethasone-Ver1.pdf

Letrozole-Palbociclib

Description: Chemotherapy Protocol Breast Cancer Letrozole-Palbociclib Regimen • Breast Cancer – Letrozole-Palbociclib Indication •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Letrozole-Palbociclib.pdf

Exemestane-Palbociclib

Description: Chemotherapy Protocol Breast Cancer Exemestane-Palbociclib Regimen • Breast Cancer – Exemestane-Palbociclib Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Exemestane-Palbociclib.pdf

Anastrozole-Palbociclib

Description: Chemotherapy Protocol Breast Cancer Anastrozole-Palbociclib Regimen • Breast Cancer – Anastrozole-Palbociclib Indicatio
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Anastrozole-Palbociclib.pdf

Annual report 2021-2022

Description: 2021/22 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2021/22 Pr
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/Annual-report-2021-2022.pdf

Enhertu (trastuzumab deruxtecan)

Description: Chemotherapy Protocol BREAST CANCER ENHERTU (trastuzumab deruxtecan) ENHERTU is NOT the same drug as Kadcyla (trastuzumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Enhertu-trastuzumab-deruxtecan.pdf

Belantamab Bortezomib Dexamethasone Weekly

Description: Chemotherapy Protocol BELANTAMAB MAFODOTIN – BORTEZOMIB - DEXAMETHASONE This protocol may require funding Regimen •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Belantamab-Bortezomib-Dexamethasone-Weekly-Ver1.pdf

Avelumab(800mg)

Description: Chemotherapy Protocol BLADDER CANCER AVELUMAB (800mg) Regimen  Bladder Cancer - Avelumab Indication  Avelumab is indicated as monother
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Avelumab800mg.pdf

11 to 20 of 89

Previous 1 2 3 4 5 … Next